Ginseng / MAPK Cancer Research Results

Gins, Ginseng: Click to Expand ⟱
Features:

Ginseng = adaptogenic herbal root from the genus Panax; main species: Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius). Active constituents: ginsenosides (Rb1, Rg1, Rg3, Rh2), polysaccharides, and other saponins.
Primary mechanisms (conceptual rank):
1) Multi-pathway signaling modulation (PI3K/Akt, MAPK, NF-κB; isoform-dependent).
2) Redox regulation (bidirectional ROS modulation; NRF2 interaction).
3) Anti-inflammatory and immunomodulatory effects.
4) Anti-proliferative and pro-apoptotic effects in cancer (notably Rg3, Rh2; dose-dependent).
5) Neurotrophic and cholinergic modulation (BDNF, ACh support).
PK / bioavailability: ginsenosides have variable oral absorption; gut microbiota convert to active metabolites (e.g., Compound K); plasma levels generally lower than many in-vitro doses.
In-vitro vs systemic exposure: many cancer studies use ≥10–100 µM; achievable plasma concentrations after oral dosing are typically lower and metabolite-driven.
Clinical evidence status: supportive oncology (fatigue reduction) supported by RCTs; direct anti-cancer efficacy largely preclinical; cognitive and fatigue benefits better substantiated.

Ginseng (Panax ginseng) – This herb has been studied for its ability to enhance the immune system.
-Antioxidant Properties: Ginseng contains ginsenosides, which have antioxidant properties.
-Immune System Support
-Inhibition of Tumor Growth
-Chemopreventive Effects
-Synergistic Effects with Cancer Treatments: ginseng may enhance the effectiveness of certain cancer treatments, such as chemotherapy, and may help reduce side effect
Dose: Standardized Extract:
Dosage: extract containing 4-7% ginsenosides 200-400mg/d
Dried Root:1-2g/d
Tea: 1-2g dried root, 1-3x/d

Ginseng (Panax spp.) — Cancer-Relevant Pathways

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 PI3K/Akt / MAPK signaling ↓ proliferation (isoform-dependent) ↔ / adaptive support R→G Growth signaling attenuation Ginsenosides Rg3/Rh2 most studied; context- and tumor-type dependent.
2 Apoptosis (caspase / mitochondrial) ↑ (dose-dependent) ↔ / protective R→G Pro-apoptotic signaling Mitochondrial depolarization reported; supra-physiologic concentrations common in vitro.
3 ROS modulation ↑ (high concentration) / ↓ (adaptive) ↓ P→R Redox modulation Bidirectional: pro-oxidant cytotoxicity in tumors at high dose; antioxidant in normal cells.
4 NF-κB / inflammation ↓ ↓ R→G Anti-inflammatory Reduces pro-tumor inflammatory microenvironment signals.
5 Angiogenesis (VEGF) ↓ (preclinical) ↔ G Anti-angiogenic Reported particularly with Rg3; human oncologic outcome data limited.
6 NRF2 axis ↔ / ↑ (adaptive) ↑ G Antioxidant enzyme induction Protective in normal tissues; tumor resistance context-dependent.
7 Clinical Translation Constraint — — — Adjunct role RCTs support fatigue reduction in cancer patients; direct anti-tumor efficacy not established.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr


Ginseng (Panax spp.) — Alzheimer’s Disease–Relevant Axes

Rank Pathway / Axis Cells (neurons/glia) TSF Primary Effect Notes / Interpretation
1 BDNF / neuroplasticity ↑ G Neurotrophic support Rg1 and metabolites reported to enhance BDNF signaling; supports cognition in mild impairment models.
2 Cholinergic modulation ↑ (mild) R→G ACh support May increase ACh release or inhibit AChE modestly; relevance additive to standard therapy unclear.
3 Neuroinflammation (NF-κB) ↓ R→G Microglial modulation Reduces pro-inflammatory cytokines in animal models.
4 ROS / oxidative stress ↓ P→R Antioxidant support Induces antioxidant enzymes; may protect against Aβ-induced oxidative injury.
5 Aβ processing ↓ (preclinical) G Reduced amyloid burden Animal studies suggest modulation of APP processing; human AD RCT data limited.
6 Clinical Translation Constraint — — Modest cognitive benefit Small human trials suggest mild cognitive improvement; not disease-modifying.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr
MAPK, mitogen-activated protein kinase: Click to Expand ⟱
Source: CGL-CS
Type:
Mitogen-activated protein kinases (MAPKs) are a group of proteins involved in transmitting signals from the cell surface to the nucleus, playing a crucial role in various cellular processes, including growth, differentiation, and apoptosis (programmed cell death).

MAPK Pathways: The MAPK family includes several pathways, the most notable being:
1.ERK (Extracellular signal-Regulated Kinase): Often associated with cell proliferation and survival.
2.JNK (c-Jun N-terminal Kinase): Typically involved in stress responses and apoptosis.
3.p38 MAPK: Associated with inflammatory responses and apoptosis.

Inhibitors: Targeting the MAPK pathway has become a strategy in cancer therapy. For example, BRAF inhibitors (like vemurafenib) are used in treating melanoma with BRAF mutations.
Altered Expression Levels:
Overexpression: Many cancers exhibit overexpression of MAPK pathway components, such as RAS, BRAF, and MEK. This overexpression can lead to increased signaling activity, promoting cell proliferation and survival.
Downregulation: In some cases, negative regulators of the MAPK pathway (e.g., MAPK phosphatases) may be downregulated, leading to enhanced MAPK signaling.
The expression levels of MAPK pathway components can serve as biomarkers for cancer diagnosis, prognosis, and treatment response. For example, high levels of phosphorylated ERK (p-ERK) may indicate active MAPK signaling and poor prognosis in certain cancers.

Numerous reports indicate that the MAPK pathway plays a major role in tumor progression and invasion, while inhibition of MAPK signaling reduces invasion.
Scientific Papers found: Click to Expand⟱
4302- Gins,    Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease
- Review, AD, NA
*neuroP↑, *Aβ↓, *p‑tau↓, *cognitive↑, *eff↑, *PKA↑, *CREB↑, *BACE↓, *ADAM10↑, *MAPK↑, *ERK↑, *PI3K↑, *Akt↑, *NRF2↑, *PPARγ↓, *IDE↑, *APP↓, *PP2A↑, *memory↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

NRF2↑, 1,  

Core Metabolism/Glycolysis ⓘ

CREB↑, 1,   PPARγ↓, 1,  

Cell Death ⓘ

Akt↑, 1,   MAPK↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

ERK↑, 1,   PI3K↑, 1,  

Migration ⓘ

APP↓, 1,   PKA↑, 1,  

Synaptic & Neurotransmission ⓘ

ADAM10↑, 1,   p‑tau↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,   BACE↓, 1,   IDE↑, 1,   PP2A↑, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,   memory↑, 1,   neuroP↑, 1,  
Total Targets: 19

Scientific Paper Hit Count for: MAPK, mitogen-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:219  Target#:181  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page